Expression of BLM helicase and TIDC in colon cancer tissues and their relationship withpostoperative prognosis of patients_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

NI Zhihai ,  XUE Zhiyou

Department of Anorectal Surgery, Xinhua Hospital Affiliated to Dalian University, Dalian, Liaoning 116021, P. R. China;

Corresponding?author：

XUE Zhiyou, Email: xuezy0506@126.com

Keywords：

colon cancer; Bloom syndrome helicase; tumor infiltrating dendritic cell; prognostic marker

DOI：

10.7507/1007-9424.202110113

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To investigate the expression of Bloom syndrome (BLM) helicase and tumor infiltrating dendritic cells (TIDC) in colon cancer tissues and their relationship with the prognosis of patients after surgery. Methods Onehundred and sixty-eight patients with colon cancer who underwent surgical resection in our hospital from June 2014 to August 2016 were selected as the research objects. The specimens of surgically resected colon cancer tissues and adjacent tissues archived by the pathology department were obtained, and the expression of BLM helicase and TIDC density were detected by immunohistochemistry. Pearson was used to analyze the correlation between BLM helicase expression and TIDC density, and the relationship between the expression of BLM helicase and TIDC density and the clinicopathological features of colon cancer was analyzed by using χ² test or Wilcoxon rank test. The influencing factors of postoperative survival of patients with colon cancer were analyzed by Cox proportional hazards regression model. Results The relative expression of BLM helicase in colon cancer tissues was higher than that in adjacent tissues (1.49±0.33 vs. 1.02±0.17), while the TIDC density was lower than that in adjacent tissues [(9.53±2.36)% vs. (12.36±2.37)%], the differences were statistically significant (P<0.05). Pearson correlation analysis showed that there was a negative correlation between the expression of BLM helicase and TIDC density (r=–0.588, P<0.05). The expression of BLM helicase and TIDC density were correlated with tumor differentiation, clinical stage and lymph node metastasis (P<0.05). That is, those with high expression of BLM helicase and low density of TIDC had low degree of tumor differentiation, late clinical grade, and higher ratio of lymph node metastasis. Sixty-three cases died (37.5%) during the follow-up period (16–60 months, medium follow up 45 months). Log-rank analysis showed that the 5-year cumulative survival rate of the BLM helicase-low expression group was higher than that of the high expression group, and that of the TIDC-low density group was lower than that of the high density group (P<0.05). Cox regression analysis showed that the high expression of BLM helicase, low density of TIDC, low degree of tumor differentiation, late stage and lymph node metastasis were risk factors affecting the postoperative survival of patients with colon cancer (P<0.05). Conclusion The abnormal expression of BLM helicase and TIDC density in colon cancer tissues are related to the degree of differentiation and lymph node metastasis, which are risk factors affecting the long-term survival of patients with colon cancer.

Citation： NI Zhihai, XUE Zhiyou. Expression of BLM helicase and TIDC in colon cancer tissues and their relationship withpostoperative prognosis of patients. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2022, 29(8): 1061-1066. doi: 10.7507/1007-9424.202110113 Copy

1.	郭天安, 謝麗, 趙江, 等. 中國結直腸癌1988-2009年發病率和死亡率趨勢分析. 中華胃腸外科雜志, 2018, 21(1): 33-40.
2.	Chen H, Luo J, Guo J. Development and validation of a five-immune gene prognostic risk model in colon cancer. BMC Cancer, 2020, 20(1): 395. doi: 10.1186/s12885-020-06799-0.
3.	Lao VV, Welcsh P, Luo Y, et al. Altered RECQ helicase expression in sporadic primary colorectal cancers. Transl Oncol, 2013, 6(4): 458-469.
4.	Bowden AR, Tischkowitz M. Clinical implications of germline mutations in breast cancer genes: RECQL. Breast Cancer Res Treat, 2019, 174(3): 553-560.
5.	Nishimura J, Tanaka H, Yamakoshi Y, et al. Impact of tumor-infiltrating LAMP-3 dendritic cells on the prognosis of esophageal squamous cell carcinoma. Esophagus, 2019, 16(4): 333-344.
6.	胡永挑, 曾小康. 直腸癌組織中腫瘤浸潤性樹突狀細胞數量和表型的改變及臨床意義. 中國普通外科雜志, 2019, 28(6): 768-772.
7.	中華人民共和國衛生和計劃生育委員會醫政醫管局, 中華醫學會腫瘤學分會. 中國結直腸癌診療規范(2017年版). 中華外科雜志, 2018, 56(4): 241-258.
8.	王妹興, 印季良, 肖謎, 等. 結腸癌組織中miR-340和CCND1表達及臨床意義. 臨床腫瘤學雜志, 2019, 24(6): 538-542.
9.	中國醫師協會外科醫師分會, 中華醫學會外科分會胃腸外科學組, 中華醫學會外科分會結直腸外科學組, 等. 中國結直腸癌肝轉移診斷和綜合治療指南(V2020). 中華胃腸外科雜志, 2021, 24(1): 1-13.
10.	Sun C, Mezzadra R, Schumacher TN. Regulation and function of the PD-L1 checkpoint. Immunity, 2018, 48(3): 434-452.
11.	Melaiu O, Chierici M, Lucarini V, et al. Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma. Nat Commun, 2020, 11(1): 5992. doi: 10.1038/s41467-020-19781-y.
12.	Bononi A, Goto K, Ak G, et al. Heterozygous germline BLM mutations increase susceptibility to asbestos and mesothelioma. Proc Natl Acad Sci U S A, 2020, 117(52): 33466-33473.
13.	Ledet EM, Antonarakis ES, Isaacs WB, et al. Germline BLM mutations and metastatic prostate cancer. Prostate, 2020, 80(2): 235-237.
14.	Shuai F, Wang B, Dong S. miR-522-3p promotes tumorigenesis in human colorectal cancer via targeting bloom syndrome protein. Oncol Res, 2018, 26(7): 1113-1121.
15.	Wang CX, Zhang ZL, Yin QK. Design, synthesis, and evaluation of new quinazolinone derivatives that inhibit bloom syndrome protein (BLM) hHelicase, trigger DNA damage at the telomere region, and synergize with PARP inhibitors. J Med Chem, 2020, 63(17): 9752-9772.
16.	閆巧輝, 邢國臣, 潘瓊. 惡性腫瘤特異生長因子和腫瘤浸潤性樹突狀細胞在子宮內膜癌患者中的表達及臨床意義. 現代腫瘤醫學, 2019, 27(5): 845-848.
17.	Kie?ler M, Plesca I, Sommer U, et al. Tumor-infiltrating plasmacytoid dendritic cells are associated with survival in human colon cancer. J Immunother Cancer, 2021, 9(3): e001813. doi: 10.1136/jitc-2020-001813.
18.	張楊蕊. DEAD-box解螺旋酶46基因沉默對乳腺癌細胞增殖和凋亡的影響. 安徽醫藥, 2020, 24(12): 2489-2493, 后插5.
19.	秦瓊, 楊林, 周愛萍, 等. 癌結節對Ⅲ期結腸癌患者預后的影響及將癌結節數目納入淋巴結計數整體評估TNM分期的探索性研究. 中華胃腸外科雜志, 2019, 22(12): 1152-1158.
20.	Balan?a CC, Salvioni A, Scarlata CM, et al. PD-1 blockade restores helper activity of tumor-infiltrating, exhausted PD-1^hiCD39⁺CD4 T cells. JCI Insight, 2021, 6(2): e142513. doi: 10.1172/jci.insight.142513.

1. 郭天安, 謝麗, 趙江, 等. 中國結直腸癌1988-2009年發病率和死亡率趨勢分析. 中華胃腸外科雜志, 2018, 21(1): 33-40.
2. Chen H, Luo J, Guo J. Development and validation of a five-immune gene prognostic risk model in colon cancer. BMC Cancer, 2020, 20(1): 395. doi: 10.1186/s12885-020-06799-0.
3. Lao VV, Welcsh P, Luo Y, et al. Altered RECQ helicase expression in sporadic primary colorectal cancers. Transl Oncol, 2013, 6(4): 458-469.
4. Bowden AR, Tischkowitz M. Clinical implications of germline mutations in breast cancer genes: RECQL. Breast Cancer Res Treat, 2019, 174(3): 553-560.
5. Nishimura J, Tanaka H, Yamakoshi Y, et al. Impact of tumor-infiltrating LAMP-3 dendritic cells on the prognosis of esophageal squamous cell carcinoma. Esophagus, 2019, 16(4): 333-344.
6. 胡永挑, 曾小康. 直腸癌組織中腫瘤浸潤性樹突狀細胞數量和表型的改變及臨床意義. 中國普通外科雜志, 2019, 28(6): 768-772.
7. 中華人民共和國衛生和計劃生育委員會醫政醫管局, 中華醫學會腫瘤學分會. 中國結直腸癌診療規范(2017年版). 中華外科雜志, 2018, 56(4): 241-258.
8. 王妹興, 印季良, 肖謎, 等. 結腸癌組織中miR-340和CCND1表達及臨床意義. 臨床腫瘤學雜志, 2019, 24(6): 538-542.
9. 中國醫師協會外科醫師分會, 中華醫學會外科分會胃腸外科學組, 中華醫學會外科分會結直腸外科學組, 等. 中國結直腸癌肝轉移診斷和綜合治療指南(V2020). 中華胃腸外科雜志, 2021, 24(1): 1-13.
10. Sun C, Mezzadra R, Schumacher TN. Regulation and function of the PD-L1 checkpoint. Immunity, 2018, 48(3): 434-452.
11. Melaiu O, Chierici M, Lucarini V, et al. Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma. Nat Commun, 2020, 11(1): 5992. doi: 10.1038/s41467-020-19781-y.
12. Bononi A, Goto K, Ak G, et al. Heterozygous germline BLM mutations increase susceptibility to asbestos and mesothelioma. Proc Natl Acad Sci U S A, 2020, 117(52): 33466-33473.
13. Ledet EM, Antonarakis ES, Isaacs WB, et al. Germline BLM mutations and metastatic prostate cancer. Prostate, 2020, 80(2): 235-237.
14. Shuai F, Wang B, Dong S. miR-522-3p promotes tumorigenesis in human colorectal cancer via targeting bloom syndrome protein. Oncol Res, 2018, 26(7): 1113-1121.
15. Wang CX, Zhang ZL, Yin QK. Design, synthesis, and evaluation of new quinazolinone derivatives that inhibit bloom syndrome protein (BLM) hHelicase, trigger DNA damage at the telomere region, and synergize with PARP inhibitors. J Med Chem, 2020, 63(17): 9752-9772.
16. 閆巧輝, 邢國臣, 潘瓊. 惡性腫瘤特異生長因子和腫瘤浸潤性樹突狀細胞在子宮內膜癌患者中的表達及臨床意義. 現代腫瘤醫學, 2019, 27(5): 845-848.
17. Kie?ler M, Plesca I, Sommer U, et al. Tumor-infiltrating plasmacytoid dendritic cells are associated with survival in human colon cancer. J Immunother Cancer, 2021, 9(3): e001813. doi: 10.1136/jitc-2020-001813.
18. 張楊蕊. DEAD-box解螺旋酶46基因沉默對乳腺癌細胞增殖和凋亡的影響. 安徽醫藥, 2020, 24(12): 2489-2493, 后插5.
19. 秦瓊, 楊林, 周愛萍, 等. 癌結節對Ⅲ期結腸癌患者預后的影響及將癌結節數目納入淋巴結計數整體評估TNM分期的探索性研究. 中華胃腸外科雜志, 2019, 22(12): 1152-1158.
20. Balan?a CC, Salvioni A, Scarlata CM, et al. PD-1 blockade restores helper activity of tumor-infiltrating, exhausted PD-1^hiCD39⁺CD4 T cells. JCI Insight, 2021, 6(2): e142513. doi: 10.1172/jci.insight.142513.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Expression of BLM helicase and TIDC in colon cancer tissues and their relationship withpostoperative prognosis of patients

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content